These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19372254)

  • 61. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hemostatic gene polymorphisms and the prevalence of thrombotic complications in polycythemia vera and essential thrombocythemia.
    Afshar-Kharghan V; López JA; Gray LA; Padilla A; Borthakur G; Roberts SC; Pruthi RK; Tefferi A
    Blood Coagul Fibrinolysis; 2004 Jan; 15(1):21-4. PubMed ID: 15166939
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
    Sankar K; Stein BL; Rampal RK
    Cancer Treat Res; 2019; 179():159-178. PubMed ID: 31317487
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Response to meta-analysis of leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera.
    Ronner L; Mascarenhas J; Moshier EL
    Blood Adv; 2019 Oct; 3(20):3010-3012. PubMed ID: 31648311
    [No Abstract]   [Full Text] [Related]  

  • 65. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2019 Jan; 94(1):133-143. PubMed ID: 30281843
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High red blood cell distribution width might predict thrombosis in essential thrombocythemia and polycythemia vera.
    Krečak I; Krečak F; Gverić-Krečak V
    Blood Cells Mol Dis; 2020 Feb; 80():102368. PubMed ID: 31669934
    [No Abstract]   [Full Text] [Related]  

  • 67. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera.
    Michiels JJ; Berneman ZN; Schroyens W; Van Vliet HH
    Platelets; 2004 Mar; 15(2):67-84. PubMed ID: 15154599
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The myeloproliferative disorders. An historical appraisal and personal experiences.
    Michiels JJ
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():1-14. PubMed ID: 8951768
    [TBL] [Abstract][Full Text] [Related]  

  • 69. New and old prognostic factors in polycythemia vera.
    Passamonti F
    Curr Hematol Malig Rep; 2009 Jan; 4(1):19-24. PubMed ID: 20425434
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort.
    Campbell PJ; MacLean C; Beer PA; Buck G; Wheatley K; Kiladjian JJ; Forsyth C; Harrison CN; Green AR
    Blood; 2012 Aug; 120(7):1409-11. PubMed ID: 22709688
    [TBL] [Abstract][Full Text] [Related]  

  • 71. How to Treat Essential Thrombocythemia and Polycythemia Vera.
    Besses C; Alvarez-Larrán A
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S114-23. PubMed ID: 27521307
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Front-line therapy in polycythemia vera and essential thrombocythemia.
    Barbui T; Finazzi MC; Finazzi G
    Blood Rev; 2012 Sep; 26(5):205-11. PubMed ID: 22784966
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.
    Reikvam H; Tiu RV
    Leukemia; 2012 Apr; 26(4):563-71. PubMed ID: 22076463
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Thrombosis in myeloproliferative neoplasms].
    Asakura H
    Rinsho Ketsueki; 2018; 59(8):1034-1041. PubMed ID: 30185703
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F.
    Tefferi A; Elliott M
    Semin Thromb Hemost; 2007 Jun; 33(4):313-20. PubMed ID: 17525888
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis.
    Ronner L; Podoltsev N; Gotlib J; Heaney ML; Kuykendall AT; O'Connell C; Shammo J; Fleischman AG; Scherber RM; Mesa R; Yacoub A; Perkins C; Meckstroth S; Behlman L; Chiaramonte M; Salehi M; Ziadkhanpour K; Nguyen H; Siwoski O; Hung AK; Janania Martinez M; Nguyen J; Patel S; Kollipara R; Dave A; Randall M; Grant M; Harrison M; Fernandez Soto P; Tremblay D; Hoffman R; Moshier E; Mascarenhas J
    Blood; 2020 May; 135(19):1696-1703. PubMed ID: 32107559
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis.
    Passamonti F; Rumi E; Caramella M; Elena C; Arcaini L; Boveri E; Del Curto C; Pietra D; Vanelli L; Bernasconi P; Pascutto C; Cazzola M; Morra E; Lazzarino M
    Blood; 2008 Apr; 111(7):3383-7. PubMed ID: 18187660
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention.
    Landolfi R; Cipriani MC; Novarese L
    Best Pract Res Clin Haematol; 2006; 19(3):617-33. PubMed ID: 16781491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.